March 18, 2025 - 13:47

As Wall Street grapples with the recent fluctuations in stock prices, futures for the Dow, S&P 500, and Nasdaq experienced a decline following a two-day rally. Investors are now questioning whether the recent sell-off signifies a potential bottom for the stock market. This uncertainty comes at a crucial time as the Federal Reserve prepares to hold its upcoming policy meeting, where key decisions regarding interest rates and economic outlook will be discussed.
Market analysts are closely monitoring the situation, weighing the implications of the Fed's actions on future market performance. The recent rally had sparked hopes for a rebound, but the current pullback raises concerns about the sustainability of such gains. As the meeting approaches, traders are likely to remain cautious, evaluating economic indicators and comments from Fed officials for clues on the central bank's future direction. The outcome of this meeting could significantly impact investor sentiment and market trends in the coming weeks.
March 27, 2026 - 07:31
Asian stocks mostly lower after Wall Street's worst day since start of Iran warFinancial markets across the Asia-Pacific region traded mostly lower on Friday, mirroring a severe downturn on Wall Street. The negative sentiment stemmed from growing investor doubts over a...
March 26, 2026 - 20:50
Better Home & Finance, Coinbase to offer mortgage backed by cryptocurrenciesA new financial partnership is bridging the worlds of digital assets and real estate. A novel mortgage program will allow prospective homebuyers to leverage their cryptocurrency investments to...
March 26, 2026 - 05:31
Is Gold a Smart Investment for Your 2026 Portfolio?As investors look ahead to 2026, many are questioning whether gold deserves a place in their financial strategy. Historically, the precious metal has been revered as a safe-haven asset, often...
March 25, 2026 - 01:51
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial ResultsPOMPANO BEACH, Fla., March 24, 2026 – BioStem Technologies, Inc., a leader in regenerative medicine, has released its financial results for the fourth quarter and full year ended December 31,...